D
DiaMedica Therapeutics D
D
DMAC
5.25000
USD
0.18
(3.55%)
Market Closed
Volume
6,007
EPS
-1
Div Yield
-
P/E
-9
Market Cap
224,493,056
Novo Nordisk Surges in Profit and Sales
6 months ago
Stocks news More
Title: DiaMedica Therapeutics
Sector: Healthcare
Industry: Biotechnology
DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.